Category: New products
-
Smart Watches Enlisted to Detect Viral Outbreaks
A research institute is asking people with smart watches and activity trackers to donate their data to find early signs of viral disease outbreaks, like Covid-19.
-
Univ. Lab Developing Self-Sanitizing Face Mask
A materials science team is creating a face mask that kills infectious virus particles, such as those spreading Covid-19, as well as blocks respiratory droplets.
-
Trial to Test Arthritis Drug for Covid-19 Pneumonia
A clinical trial is beginning soon that tests a current drug for rheumatoid arthritis as a treatment for severe pneumonia in patients with Covid-19 infections.
-
Engineered Blood Cells Created for Cancer Therapies
An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers.
-
Univ Labs Developing Covid-19, Outbreak Test Devices
Two university labs are creating tests or monitoring devices to detect novel coronavirus, or Covid-19 viruses, and spot other viral outbreaks when they occur.
-
New Venture Formed to Discover Neuro Therapies
Two drug discovery companies are forming a joint venture to discover treatments for neurological conditions based on cannabinoid-like compounds.
-
A.I.-Enabled Insole Captures, Measures Step Info
An engineering lab developed an electronic shoe insole that gathers data for analysis with artificial intelligence to accurately measure a person’s gait patterns.
-
Case Study Maps Covid-19 Immune Response
Infectious disease specialists in Australia tracked the course of an early patient’s immune-system response to non-severe novel coronavirus, or Covid-19, infections.
-
Patch Delivers Low-Dose Vaccine with Full-Dose Power
A clinical trial shows a polymer patch with one-sixth of the usual influenza vaccine dose generates about the same immune reaction as a full-dose injection.
-
Lilly, Biotech, NIH to Develop Covid-19 Antibodies
Drug maker Eli Lilly and Co., a biotechnology company, and an agency of NIH are collaborating on antibodies for novel coronavirus vaccines and therapies.